Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

Authors :: Loras, C.
Gisbert, J.P.
Minguez, M.
Merino, O.
Bujanda, L.
Saro, C.
Domenech, E.
Barrio, J.
Andreu, M.
Ordas, I.
Vida, L.
Bastida, G.
Gonzalez-Huix, F.
Piqueras, M.
Ginard, D.
Calvet, X.
Gutierrez, A.
Abad, A.
Torres, M.
Panes, J.
Chaparro, M.
Pascual, I.
Rodriguez-Carballeira, M.
Fernandez-Banares, F.
Viver, J.M.
Esteve, M.
Source :: Gut. Oct, 2010, Vol. 59 Issue 10, p1340, 7 p.
Publication Year :: 2010

Subjects :: Liver diseases -- Risk factors
Inflammatory bowel diseases -- Care and treatment
Inflammatory bowel diseases -- Patient outcomes
Immunosuppressive agents -- Usage
Immunosuppressive agents -- Health aspects
Hepatitis B -- Risk factors
Health

Tools